<!DOCTYPE html>
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title>input-it</title>
</head>
<body><div id="lawcontent">
<div id="preface">
<h1 class="erlasstitel botschafttitel">Ordinanza del DEFR <br>concernente la costituzione di scorte obbligatorie di medicamenti</h1>
<p class="man-template-datum-aend">Modifica del 13 novembre 2025</p>
</div>
<div id="preamble"><div>
<p class="man-template-autor man-space-before-10">Il Dipartimento federale dell’economia, della formazione e della ricerca (DEFR)</p>
<p class="man-template-verb man-space-before-3 man-space-after-18">ordina:</p>
</div></div>
<main id="maintext"><section id="lvl_I"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#lvl_I">I</a>
</h1>
<div class="collapseable">
<p class="absatz man-space-before-4">L’ordinanza del DEFR del 20 maggio 2019<sup><a href="#fn-d3402e22" id="fnbck-d3402e22">1</a></sup> concernente la costituzione di scorte obbligatorie di medicamenti è modificata come segue:</p>
<article class="man-art-mod" id="mod_u1"><a name=""></a><h6 class="heading man-mod-ref man-font-style-italic man-space-before-14" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#mod_u1">Art. 8 cpv. 1</a>
</h6>
<div class="collapseable"><p class="absatz man-space-before-4"><sup>1</sup> Previa consultazione della cooperativa Helvecura (Helvecura) l’UFAE può concordare con gli assoggettati all’obbligo di costituire scorte che fabbricano interamente i loro prodotti in Svizzera la possibilità di depositare le merci sotto forma di principi attivi.</p></div></article><article class="man-art-mod" id="mod_u2"><a name=""></a><h6 class="heading man-mod-ref man-font-style-italic man-space-before-14" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#mod_u2">Art. 11 cpv. 1</a>
</h6>
<div class="collapseable"><p class="absatz man-space-before-4"><sup>1</sup> I proprietari di scorte obbligatorie possono ricorrere alla costituzione di scorte obbligatorie da parte di terzi o in comune per una parte o per il totale dei propri quantitativi.</p></div></article><div class="footnotes"><p id="fn-d3402e22"><sup><a href="#fnbck-d3402e22">1</a></sup><sup></sup>  <a href="https://fedlex.data.admin.ch/vocabulary/legal-taxonomy/7699" target="_blank" data-rs-uri="https://fedlex.data.admin.ch/eli/cc/2019/351" data-rs="531.215.311" data-lang="it">RS <b>531.215.311</b></a></p></div>
</div></section><section id="lvl_II"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#lvl_II">II</a>
</h1>
<div class="collapseable"><p class="absatz man-space-before-4">L’allegato 1 è modificato secondo la versione qui annessa.</p></div></section><section id="lvl_III"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#lvl_III">III</a>
</h1>
<div class="collapseable">
<p class="absatz man-space-before-4">La presente ordinanza entra in vigore il 15 gennaio 2026.</p>
<p></p>
<div class="table layout-table"><table>
			
			
			<tr>
				
				
				<td>
					
					<p class="unterschriftenfi1 man-space-before-24">13 novembre 2025</p>
				</td>
				<td>
					
					<p class="unterschriftenfi1 man-space-before-24">Dipartimento federale dell’economia, della formazione e della ricerca:</p>
					<p class="unterschriftenfi man-space-before-6">Guy Parmelin</p>
				</td>
			</tr>
		</table></div>
</div></section></main><div id="annex"><section id="annex_1"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1">Allegato 1</a>
</h1>
<div class="collapseable">
<p class="titelanhtext">(art. 1)</p>
<section id="annex_1/lvl_u1"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_u1">Merci secondo l’articolo 1</a>
</h2>
<div class="collapseable">
<article class="man-art-mod" id="annex_1/lvl_u1/mod_u1"><a name=""></a><h6 class="heading man-mod-ref man-font-style-italic man-space-before-14" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_u1/mod_u1">N. 4 e 5b</a>
</h6>
<div class="collapseable"></div></article><section id="annex_1/lvl_u1/lvl_4"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_u1/lvl_4">4 Analgesici della medicina umana</a>
</h3>
<div class="collapseable">
<p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class="man-text-align-left">
					
					<p class="man-template-tab-kpf man-space-before-3 man-space-after-3">Codice ATC</p>
				</th>
				<th class="man-text-align-left">
					
					<p class="man-template-tab-kpf man-space-before-3 man-space-after-3">Designazione della merce</p>
				</th>
				<th class="man-text-align-left">
					
					<p class="man-template-tab-kpf man-space-before-3 man-space-after-3">Osservazioni</p>
				</th>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-4">N01AH06</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-4">remifentanil</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-4"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">N02AA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">morfina</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">N02AA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">idromorfone </p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">N02AA05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">ossicodone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">N02AA55</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">combinazioni tra ossicodone e naloxone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">N02AB03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">fentanile</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">N02AE01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">buprenorfina</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">N02BA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">acido acetilsalicilico, incl. acetilsalicilato di lisina</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">forme parenterali</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">N07BC02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">metadone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-after-3">N07BC05</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-after-3">levometadone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-after-3"></p>
				</td>
			</tr>
		</table></div>
</div></section><section id="annex_1/lvl_u1/lvl_5_b"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_u1/lvl_5_b">5<span class="man-font-weight-normal"><i>b</i></span> Altri medicamenti della medicina umana</a>
</h3>
<div class="collapseable">
<p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class="man-text-align-left">
					
					<p class="man-template-tab-kpf man-space-before-3 man-space-after-3">Codice ATC</p>
				</th>
				<th class="man-text-align-left">
					
					<p class="man-template-tab-kpf man-space-before-3 man-space-after-3">Designazione della merce</p>
				</th>
				<th class="man-text-align-left">
					
					<p class="man-template-tab-kpf man-space-before-3 man-space-after-3">Osservazioni</p>
				</th>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-before-4">B01AD02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-4">alteplasi</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-before-4">dosaggio &gt; 2 mg</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">C01CA03</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">noradrenalina</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">C01CA07</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">dobutamina</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">C01CA24</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">adrenalina</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">autoiniettori</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">C03CA01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">furosemide</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">forme parenterali</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">C07AB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">metoprololo</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">forme parenterali</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">C07AG01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">labetalolo</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">forme parenterali</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">H01BB02</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">ossitocina</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">forme parenterali</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">H02AB01</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">betametasone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">forme perorali</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">H02AB09</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">idrocortisone</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">forme perorali</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">M03AC09</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">rocuronio bromuro</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">N01AX10</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">propofol</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">N05BA06</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">lorazepam</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">forme parenterali</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr">V08BA</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr">mezzi di contrasto radiografici contenenti solfato di bario</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr"></p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p class="man-template-tab-krpr man-space-after-3">V08DA</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-after-3">mezzi di contrasto per ultrasonologia</p>
				</td>
				<td>
					
					<p class="man-template-tab-krpr man-space-after-3"></p>
				</td>
			</tr>
		</table></div>
<p class="abstand1seite man-space-before-0"></p>
</div></section>
</div></section>
</div></section></div>
</div></body>
</html>
